Hsbc Holdings PLC Sells 23,598 Shares of Inspire Medical Systems, Inc. $INSP

Hsbc Holdings PLC reduced its position in Inspire Medical Systems, Inc. (NYSE:INSP) by 54.5% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 19,730 shares of the company’s stock after selling 23,598 shares during the period. Hsbc Holdings PLC’s holdings in Inspire Medical Systems were worth $997,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of INSP. New York State Teachers Retirement System lifted its stake in shares of Inspire Medical Systems by 9.3% in the 1st quarter. New York State Teachers Retirement System now owns 23,599 shares of the company’s stock worth $1,217,000 after purchasing an additional 2,004 shares during the period. Y Intercept Hong Kong Ltd grew its position in Inspire Medical Systems by 124.1% during the first quarter. Y Intercept Hong Kong Ltd now owns 158,274 shares of the company’s stock valued at $8,164,000 after buying an additional 87,639 shares during the period. Leonteq Securities AG grew its position in Inspire Medical Systems by 187.3% during the first quarter. Leonteq Securities AG now owns 22,812 shares of the company’s stock valued at $1,177,000 after buying an additional 14,873 shares during the period. Elevation Point Wealth Partners LLC purchased a new stake in Inspire Medical Systems during the first quarter valued at approximately $438,000. Finally, Apollon Wealth Management LLC increased its holdings in Inspire Medical Systems by 5.6% during the first quarter. Apollon Wealth Management LLC now owns 3,997 shares of the company’s stock valued at $206,000 after buying an additional 212 shares during the last quarter. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Stock Up 2.0%

NYSE:INSP opened at $51.93 on Wednesday. The business’s 50-day simple moving average is $45.61 and its two-hundred day simple moving average is $56.43. The stock has a market cap of $1.50 billion, a PE ratio of 11.57, a P/E/G ratio of 5.16 and a beta of 0.71. Inspire Medical Systems, Inc. has a 52 week low of $38.91 and a 52 week high of $147.03.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Monday, May 4th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of ($0.28) by $0.38. The business had revenue of $204.58 million for the quarter, compared to the consensus estimate of $200.04 million. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.The business’s revenue was up 1.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.10 earnings per share. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. Sell-side analysts anticipate that Inspire Medical Systems, Inc. will post 0.93 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on INSP. Evercore cut shares of Inspire Medical Systems from an “outperform” rating to an “in-line” rating and set a $40.00 price target on the stock. in a research note on Tuesday, June 23rd. Robert W. Baird decreased their target price on Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. Summit Redstone set a $39.00 target price on Inspire Medical Systems in a research report on Friday, May 22nd. Truist Financial upped their price target on Inspire Medical Systems from $50.00 to $54.00 and gave the stock a “hold” rating in a research report on Thursday, July 16th. Finally, Mizuho lowered their price objective on Inspire Medical Systems from $70.00 to $55.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, thirteen have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $73.28.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.